DiaMedica Therapeutics(DMAC) - 2022 Q4 - Earnings Call Transcript

Scott Kellen Thanks, Rick, and good morning, everyone. As Rick mentioned, we announced our full year 2022 financial results and filed our annual report on Form 10-K yesterday afternoon. These documents are both available on either the DiaMedica or the SEC websites. Starting with our balance sheet as of December 31, 2022, our combined cash and investments totaled $33.5 million, down $2.6 million from $36.1 million as of the end of Q3 2022 and down $11.6 million from $45.1 million as of our prior year end. Th ...